tiprankstipranks
Trending News
More News >
Tianda Pharmaceuticals Ltd. (HK:0455)
:0455
Hong Kong Market

Tianda Pharmaceuticals Ltd. (0455) Income Statement

Compare
0 Followers

Tianda Pharmaceuticals Ltd. Income Statement

Last quarter (Q2 2024), Tianda Pharmaceuticals Ltd.'s total revenue was HK$156.07M, a decrease of -60.48% from the same quarter last year. In Q2, Tianda Pharmaceuticals Ltd.'s net income was HK$-27.24M. See Tianda Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
HK$ 329.94MHK$ 532.09MHK$ 546.69MHK$ 509.96MHK$ 474.33M
Gross Profit
HK$ 152.02MHK$ 255.53MHK$ 251.52MHK$ 241.22MHK$ 258.99M
Operating Expenses
HK$ 206.17MHK$ 284.56MHK$ 321.66MHK$ 283.25MHK$ 290.20M
Depreciation and Amortization
HK$ 0.00HK$ 36.41MHK$ 50.25MHK$ 22.15MHK$ 20.62M
EBITDA
HK$ -49.49MHK$ 15.66MHK$ -19.89MHK$ -5.14MHK$ -6.25M
Operating Income
HK$ -54.15MHK$ -29.02MHK$ -70.14MHK$ -38.97MHK$ -26.76M
Other Income/Expenses
HK$ -191.00KHK$ 3.33MHK$ 6.29MHK$ 10.96MHK$ 3.77M
Pretax Income
HK$ -54.34MHK$ -25.69MHK$ -63.85MHK$ -28.02MHK$ -27.44M
Net Income
HK$ -61.37MHK$ -24.16MHK$ -54.64MHK$ -21.67MHK$ -25.92M
Per Share Metrics
Basic EPS
HK$ -0.03HK$ -0.01HK$ -0.03HK$ -0.01HK$ -0.01
Diluted EPS
HK$ -0.03HK$ -0.01HK$ -0.03HK$ -0.01HK$ -0.01
Weighted Average Shares Outstanding
2.15B 2.15B 2.15B 2.15B 2.15B
Weighted Average Shares Outstanding (Diluted)
2.15B 2.15B 2.15B 2.15B 2.15B
Currency in HKD

Tianda Pharmaceuticals Ltd. Earnings and Revenue History